**6. References**

	- [10] Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel of detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2488 - 97
	- [11] Backers JM. Effect of Lipid-Lowering Drug Therapy on Small-dense Low-Dense Lipoprotein. Ann Pharmacol 2005; 39: 523 - 26.
	- [12] Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495-506
	- [13] Chait A, Brazo RL, Tribble DL, Krauss RM. Susceptibility of small, low- density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Amer J Med 1993; 94: 350-6
	- [14] Van J, Pan J, Charles MA, Krauss R, Wong N, Wu X. Atherogenic lipid phenotype in a general group of subjects. Arch Pathol Lab Medicine 2007; 131: 1679 – 85
	- [15] Castelli WP. Cholesterol and lipids in the risk of coronary artery disease The Framingham Heart Study. Can J Cardiol 1988; (Suppl A): 5A-10A.
	- [16] Castelli WP. Epidemiology of triglycerides; a view from Framingham. Am J Cardiol 1992; 70: 43-49
	- [17] Castelli WP. The new pathophysiology of coronary artery disease. Am J Cardiol 1998; 82: (Suppl 2): 60-85
	- [18] Nicholls S, Lundmann P (2004). The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol. Semin Vasc Med 2004; 4: 187-195
	- [19] Rizzo M, Berneis K. Low density lipoprotein size and cardiovascular prevention. Europ J Int Med 2006; 17: 77 - 80.
	- [20] Shoji T, Hatsuda S, Tsuchikura S, Shinohara K, Komoto E, Kovama H, Emoto M, Nishizhawa Y. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis. Atherosclerosis 2009; 202: 582 - 588.
	- [21] Zhao ChX, Cui YH, Fan Q, Wang PH, Hui R, Cianflone K, Wang DW. Small Dense Low-Density Lipoproteins and Associated Risk Factors in Patients with Stroke. Cerebrovasc Dis 2009; 27: 99-104.
	- [22] Rainwater DL, Moore PH jr, Shelledy WR, Dyer TD, Slifer SH. Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res 1997; 38: 1261-1266
	- [23] Alabakovska SB, Todorova BB, Labudovic DD, Tosheska KN. Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and size phenotyping in healthy Macedonians. Clin Chim Acta 2002; 317: 119-123.
	- [24] Otvos JD, Jeyarajah EJ, Bennet SW, Krauss RM.Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma protein concentrations and subspecies distribution from a single, rapid measurement. Clin Chem 1992; 38: 1632- 38
	- [25] Hoefner DM, Hodel SD, O´Brien JF, Branum EL, Sun D, Meissner I, McConnell JP. Development of a rapid quantitative method for LDL subfraction with use of the Quantimetrix Lipoprint LDL system. Clin Chem 2001; 472: 266-274.

[26] Lamarche B, Lemieux I, Despres JP. The small, dense LDL phenotype and the risk of coronary heart disease : epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 1999; 25: 199-211

92 Lipoproteins – Role in Health and Diseases

1992; 70: 43-49

82: (Suppl 2): 60-85

1997; 38: 1261-1266

Chem 1992; 38: 1632- 38

J Int Med 2006; 17: 77 - 80.

Cerebrovasc Dis 2009; 27: 99-104.

[10] Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel of detection, evaluation and treatment of high blood

[11] Backers JM. Effect of Lipid-Lowering Drug Therapy on Small-dense Low-Dense

[12] Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495-506 [13] Chait A, Brazo RL, Tribble DL, Krauss RM. Susceptibility of small, low- density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein

[14] Van J, Pan J, Charles MA, Krauss R, Wong N, Wu X. Atherogenic lipid phenotype in a

[15] Castelli WP. Cholesterol and lipids in the risk of coronary artery disease – The

[16] Castelli WP. Epidemiology of triglycerides; a view from Framingham. Am J Cardiol

[17] Castelli WP. The new pathophysiology of coronary artery disease. Am J Cardiol 1998;

[18] Nicholls S, Lundmann P (2004). The emerging role of lipoproteins in atherogenesis:

[19] Rizzo M, Berneis K. Low density lipoprotein size and cardiovascular prevention. Europ

[20] Shoji T, Hatsuda S, Tsuchikura S, Shinohara K, Komoto E, Kovama H, Emoto M, Nishizhawa Y. Small dense low-density lipoprotein cholesterol concentration and

[21] Zhao ChX, Cui YH, Fan Q, Wang PH, Hui R, Cianflone K, Wang DW. Small Dense Low-Density Lipoproteins and Associated Risk Factors in Patients with Stroke.

[22] Rainwater DL, Moore PH jr, Shelledy WR, Dyer TD, Slifer SH. Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res

[23] Alabakovska SB, Todorova BB, Labudovic DD, Tosheska KN. Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and

[25] Hoefner DM, Hodel SD, O´Brien JF, Branum EL, Sun D, Meissner I, McConnell JP. Development of a rapid quantitative method for LDL subfraction with use of the

size phenotyping in healthy Macedonians. Clin Chim Acta 2002; 317: 119-123. [24] Otvos JD, Jeyarajah EJ, Bennet SW, Krauss RM.Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma protein concentrations and subspecies distribution from a single, rapid measurement. Clin

Quantimetrix Lipoprint LDL system. Clin Chem 2001; 472: 266-274.

general group of subjects. Arch Pathol Lab Medicine 2007; 131: 1679 – 85

Framingham Heart Study. Can J Cardiol 1988; (Suppl A): 5A-10A.

beyond LDL cholesterol. Semin Vasc Med 2004; 4: 187-195

carotid atherosclerosis. Atherosclerosis 2009; 202: 582 - 588.

cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2488 - 97

Lipoprotein. Ann Pharmacol 2005; 39: 523 - 26.

phenotype, pattern B. Amer J Med 1993; 94: 350-6


men : 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 2005; 25: 553-559

